Ptc Therapeutics (PTCT) Net Margin Growth (5y) (2017 - 2026)

Ptc Therapeutics (PTCT) Net Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Ptc Therapeutics 6.34 Bn 4.45 Bn 244.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10,804.00
Dec 31, 2025 -45,744.00
Sep 30, 2025 6,639.00
Jun 30, 2025 20,488.00
Mar 31, 2025 23,877.00
Dec 31, 2024 -23,218.00
Sep 30, 2024 2,987.00
Mar 31, 2024 9,234.00
Dec 31, 2023 565.00
Sep 30, 2023 2,849.00
Jun 30, 2023 156,841.00
Mar 31, 2023 -2,864.00
Dec 31, 2022 -10,427.00
Sep 30, 2022 3,041.00
Jun 30, 2022 -5,539.00
Mar 31, 2022 2,469.00
Dec 31, 2021 3.71 Mn
Sep 30, 2021 351,798.00
Jun 30, 2021 1.98 Mn
Mar 31, 2021 10,935.00